SCHEMBL18403102

SCHEMBL18403102

FC(F)(F)c1cccnc1[SiH3]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.43
SLC40A1 Q9NP59 1/20 0.39
SLC22A12 Q96S37 1/20 0.38
NFE2L2 Q16236 4/20 0.37
HSD11B1 P28845 2/20 0.37
MEN1 O00255 1/20 0.37
TNF P01375 1/20 0.37
CXCL8 P10145 1/20 0.37
KMT2A Q03164 1/20 0.37
PAX8 Q06710 1/20 0.37
KLF5 Q13887 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
LMNA P02545 1/20 0.37
ALDH1A1 P00352 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15624412 0.76 TRPV1 (0.47) EPHX2TRPV1
SCHEMBL31608519 0.74 EPHX2 (0.44) EPHX2SLC40A1NFE2L2HSD11B1MEN1
SCHEMBL31009386 0.74 EPHX2 (0.44) EPHX2NFE2L2HSD11B1MEN1TNF
SCHEMBL610024 0.74 EPHX2 (0.44) EPHX2NFE2L2HSD11B1MEN1TNF
SCHEMBL8436654 0.74 EPHX2 (0.44) EPHX2SLC40A1NFE2L2HSD11B1MEN1
SCHEMBL2305693 0.73 EPHX2 (0.43) EPHX2SLC40A1SLC22A12NFE2L2HSD11B1
SCHEMBL162911 0.73 EPHX2 (0.43) EPHX2NFE2L2HSD11B1MEN1TNF
SCHEMBL120643 0.73 RPS6KA5 (0.45) EPHX2NFE2L2HSD11B1MEN1TNF
SCHEMBL6966993 0.73 EPHX2 (0.43) EPHX2SLC40A1NFE2L2HSD11B1MEN1
SCHEMBL1313342 0.73 EPHX2 (0.47) EPHX2NFE2L2HSD11B1MEN1TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210061764-A1 BIVALENT LINKERS AND CONJUGATES THEREOF ENDOCYTE INC (US) 2021-03-04 US disclosed
US-10647676-B2 Bivalent linkers and conjugates thereof ENDOCYTE, INC. (US) 2020-05-12 US disclosed
US-20190300482-A1 BIVALENT LINKERS AND CONJUGATES THEREOF ENDOCYTE INC (US) 2019-10-03 US disclosed
US-20190100494-A1 BIVALENT LINKERS AND CONJUGATES THEROF ENDOCYTE INC (US) 2019-04-04 US disclosed
US-20170320826-A1 BIVALENT LINKERS AND CONJUGATES THEREOF ENDOCYTE INC (US) 2017-11-09 US disclosed
US-9550734-B2 Bivalent linkers and conjugates thereof ENDOCYTE, INC. (US) 2017-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190100494-A1 BIVALENT LINKERS AND CONJUGATES THEROF PAICS, MTHFD2, BTD EPHX2 66/4885SLC40A1 216/4885SLC22A12 764/4885
US-10647676-B2 Bivalent linkers and conjugates thereof VDR, ERBB2, FOLR1 EPHX2 41/4885SLC40A1 235/4885SLC22A12 371/4885
US-20210061764-A1 BIVALENT LINKERS AND CONJUGATES THEREOF PAICS, FOLR2, DCLRE1A EPHX2 31/4885SLC40A1 236/4885SLC22A12 676/4885
US-20190300482-A1 BIVALENT LINKERS AND CONJUGATES THEREOF PAICS, FOLR2, DCLRE1A EPHX2 31/4885SLC40A1 236/4885SLC22A12 676/4885
US-20170320826-A1 BIVALENT LINKERS AND CONJUGATES THEREOF PAICS, FOLR2, DCLRE1A EPHX2 31/4885SLC40A1 236/4885SLC22A12 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.